Caglayan, V., Onen, E., Avci, S., Sambel, M., Kilic, M., Oner, S., Aydos, M., & Yıldız, H. (2019). Lymphocyte-to-monocyte ratio is a valuable marker to predict prostate cancer in patients with prostate specific antigen between 4 and 10 ng/dl. Archivio Italiano Di Urologia E Andrologia, 90(4), 270-275. https://doi.org/10.4081/aiua.2018.4.270